{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:19:20Z","timestamp":1790900360620,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP11188166, OPP1204628, INV-001927"],"award-info":[{"award-number":["OPP11188166, OPP1204628, INV-001927"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004417","name":"Global Fund to Fight AIDS, Tuberculosis and Malaria","doi-asserted-by":"publisher","award":["QSE-M-UNOPS-MORU-20864-007-44"],"award-info":[{"award-number":["QSE-M-UNOPS-MORU-20864-007-44"]}],"id":[{"id":"10.13039\/100004417","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Genetic surveillance of\n                    <jats:italic>Plasmodium falciparum<\/jats:italic>\n                    (\n                    <jats:italic>Pf<\/jats:italic>\n                    ) can track antimalarial-resistant strains, to inform decision-making by National Malaria Control Programmes (NMCPs). The GenRe-Mekong project prospectively collected 5982 samples in the Greater Mekong Subregion (GMS) between 2017 and 2022, genotyping drug resistance markers, and barcodes that recapitulate genetic variation. Genotypes were analyzed with the grcMalaria R package, first described in this paper, to translate genetic epidemiology data into actionable visual information. Since 2020,\n                    <jats:italic>Pf<\/jats:italic>\n                    incidences decreased rapidly, accompanied by a decline of dihydroartemisinin-piperaquine (DHA-PPQ) resistant lineages, previously dominant in the eastern GMS. The frequency of\n                    <jats:italic>plasmepsin2\/3<\/jats:italic>\n                    amplifications, conferring piperaquine resistance, dropped from 62% in 2017-2019 to 2% in 2022, coinciding with a switch in frontline therapy in Cambodia, Thailand, and Vietnam. While regional artemisinin resistance levels remained high, no evidence of emerging mefloquine resistance was found. Routine genetic surveillance proved valuable in monitoring rapid parasite population changes in response to public health interventions, providing actionable information for NMCPs.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-59946-1","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T10:49:12Z","timestamp":1747738152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Genetic surveillance of Plasmodium falciparum populations following treatment policy revisions in the Greater Mekong Subregion"],"prefix":"10.1038","volume":"16","author":[{"given":"Varanya","family":"Wasakul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tess D.","family":"Verschuuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4101-5706","authenticated-orcid":false,"given":"Nguyen","family":"Thuy-Nhien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huynh Hong","family":"Quang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngo Duc","family":"Thang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keobouphaphone","family":"Chindavongsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siv","family":"Sovannaroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virasak","family":"Banouvong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viengphone","family":"Sengsavath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayfong","family":"Mayxay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi Kim","family":"Tuyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vo Ngoc Lam","family":"Phuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4268-7498","authenticated-orcid":false,"given":"Pham","family":"Duc Trung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f3nia","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonexay","family":"Phalivong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiamphone","family":"Xayvanghang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supaporn","family":"Mahaphontrakoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7386-3566","authenticated-orcid":false,"given":"Richard D.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul N.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5355-0562","authenticated-orcid":false,"given":"Richard J.","family":"Maude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina V.","family":"Ariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria J.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas P.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5190-2395","authenticated-orcid":false,"given":"Arjen M.","family":"Dondorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8060-6771","authenticated-orcid":false,"given":"Olivo","family":"Miotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"59946_CR1","unstructured":"World Health Organization. World Malaria Report 2022. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2022 (2022)."},{"key":"59946_CR2","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1111\/j.1365-3156.2006.01739.x","volume":"11","author":"MB Denis","year":"2006","unstructured":"Denis, M. B. et al. Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia. Trop. Med. Int. Health 11, 1800\u20131807 (2006).","journal-title":"Trop. Med. Int. Health"},{"key":"59946_CR3","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1111\/j.1365-3156.2006.01690.x","volume":"11","author":"MB Denis","year":"2006","unstructured":"Denis, M. B. et al. Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia. Trop. Med. Int. Health 11, 1360\u20131366 (2006).","journal-title":"Trop. Med. Int. Health"},{"key":"59946_CR4","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","volume":"19","author":"RW van der Pluijm","year":"2019","unstructured":"van der Pluijm, R. W. et al. Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study. Lancet Infect. Dis. 19, 952\u2013961 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"59946_CR5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/cid\/ciaa628","volume":"73","author":"M Mairet-Khedim","year":"2021","unstructured":"Mairet-Khedim, M. et al. Clinical and in vitro resistance of Plasmodium falciparum to artesunate-amodiaquine in Cambodia. Clin. Infect. Dis. 73, 406\u2013413 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"59946_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-017-1712-4","volume":"16","author":"MM Plucinski","year":"2017","unstructured":"Plucinski, M. M. et al. Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015. Malar. J. 16, 62 (2017).","journal-title":"Malar. J."},{"key":"59946_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33873-x","volume":"13","author":"PK Tumwebaze","year":"2022","unstructured":"Tumwebaze, P. K. et al. Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda. Nat. Commun. 13, 6353 (2022).","journal-title":"Nat. Commun."},{"key":"59946_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp, A. M. et al. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361, 455\u2013467 (2009).","journal-title":"N. Engl. J. Med."},{"key":"59946_CR9","doi-asserted-by":"publisher","unstructured":"Jacob, C. G. et al. Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination. Elife 10, https:\/\/doi.org\/10.7554\/eLife.62997 (2021).","DOI":"10.7554\/eLife.62997"},{"key":"59946_CR10","doi-asserted-by":"publisher","first-page":"e063456","DOI":"10.1136\/bmjopen-2022-063456","volume":"12","author":"A Mayor","year":"2022","unstructured":"Mayor, A. et al. Prospective surveillance study to detect antimalarial drug resistance, gene deletions of diagnostic relevance and genetic diversity of Plasmodium falciparum in Mozambique: protocol. BMJ Open 12, e063456 (2022).","journal-title":"BMJ Open"},{"key":"59946_CR11","unstructured":"Miotto, O. Genetic epidemiology use cases for malaria control programmes: a methodology. https:\/\/www.malariagen.net\/resource\/genetic-epidemiology-use-cases-malaria-control-programmes-methodology\/ (2023)."},{"key":"59946_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S1473-3099(16)30409-1","volume":"17","author":"R Amato","year":"2017","unstructured":"Amato, R. et al. Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study. Lancet Infect. Dis. 17, 164\u2013173 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"59946_CR13","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S1473-3099(19)30392-5","volume":"19","author":"WL Hamilton","year":"2019","unstructured":"Hamilton, W. L. et al. Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study. Lancet Infect. Dis. 19, 943\u2013951 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"59946_CR14","unstructured":"World Health Organization. Guidelines for the treatment of malaria. https:\/\/iris.who.int\/handle\/10665\/162441 (2015)."},{"key":"59946_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","volume":"16","author":"C Amaratunga","year":"2016","unstructured":"Amaratunga, C. et al. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect. Dis. 16, 357\u2013365 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"59946_CR16","unstructured":"World Health Organization. The Mekong Malaria Elimination programme. Accelerating malaria elimination in the Greater Mekong. https:\/\/www.who.int\/publications\/i\/item\/WHO-UCN-GMP-MME-2022.01 (2022)."},{"key":"59946_CR17","unstructured":"Cambodia: National Center for Parasitology, E. a. M. C. National Center for Parasitology, Entomology and Malaria Control: National Malaria Programme Review 2019 (National Center for Parasitology, E. a. M. C., 2019)."},{"key":"59946_CR18","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S1473-3099(21)00692-7","volume":"22","author":"TJ Peto","year":"2022","unstructured":"Peto, T. J. et al. Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial. Lancet Infect. Dis. 22, 867\u2013878 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"59946_CR19","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01121-21","volume":"65","author":"M Imwong","year":"2021","unstructured":"Imwong, M. et al. Evolution of multidrug resistance in Plasmodium falciparum: a longitudinal study of genetic resistance markers in the Greater Mekong Subregion. Antimicrob. Agents Chemother. 65, e0112121 (2021).","journal-title":"Antimicrob. Agents Chemother."},{"key":"59946_CR20","unstructured":"Ministry of Health, Socialist Republic of Vietnam. National Guideline of Malaria Diagnosis and Treatment. https:\/\/thuvienphapluat.vn\/van-ban\/The-thao-Y-te\/Quyet-dinh-2699-QD-BYT-2020-ban-hanh-Huong-dan-chan-doan-dieu-tri-benh-Sot-ret-448276.aspx (2020)."},{"key":"59946_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-023-04763-4","volume":"22","author":"VAT Cao","year":"2023","unstructured":"Cao, V. A. T. et al. Exploring the feasibility of introducing triple artemisinin-based combination therapy in the malaria treatment policy in Vietnam. Malar. J. 22, 326 (2023).","journal-title":"Malar. J."},{"key":"59946_CR22","unstructured":"The Mekong Malaria Elimination Programme. Accelerating malaria elimination in the Greater Mekong. Bulletin 10, March 2022. (World Health Organization, Geneva, 2022)."},{"key":"59946_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-021-03791-2","volume":"20","author":"P Sudathip","year":"2021","unstructured":"Sudathip, P. et al. Progress and challenges of integrated drug efficacy surveillance for uncomplicated malaria in Thailand. Malar. J. 20, 261 (2021).","journal-title":"Malar. J."},{"key":"59946_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-017-2104-5","volume":"16","author":"N Simmalavong","year":"2017","unstructured":"Simmalavong, N. et al. Expanding malaria diagnosis and treatment in Lao PDR: lessons learned from a public-private mix initiative. Malar. J. 16, 460 (2017).","journal-title":"Malar. J."},{"key":"59946_CR25","doi-asserted-by":"publisher","first-page":"7067","DOI":"10.1073\/pnas.1505691112","volume":"112","author":"RF Daniels","year":"2015","unstructured":"Daniels, R. F. et al. Modeling malaria genomics reveals transmission decline and rebound in Senegal. Proc. Natl Acad. Sci. USA 112, 7067\u20137072 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59946_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgac187","volume":"1","author":"W Wong","year":"2022","unstructured":"Wong, W. et al. R (H): a genetic metric for measuring intrahost Plasmodium falciparum relatedness and distinguishing cotransmission from superinfection. PNAS Nexus 1, pgac187 (2022).","journal-title":"PNAS Nexus"},{"key":"59946_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.953187","volume":"12","author":"JH Kattenberg","year":"2022","unstructured":"Kattenberg, J. H. et al. Novel highly-multiplexed AmpliSeq targeted assay for Plasmodium vivax genetic surveillance use cases at multiple geographical scales. Front. Cell Infect. Microbiol. 12, 953187 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"59946_CR28","unstructured":"World Health Organization. Mekong Malaria Elimination Programme: Epidemiology Summary, Vol. 4. (World Health Organization, Geneva, 2018)."},{"key":"59946_CR29","unstructured":"World Health Organization. Mekong Malaria Elimination Programme: Epidemiology Summary, Vol. 12. World Health Organization, Geneva. (2020)."},{"key":"59946_CR30","unstructured":"World Health Organization. Mekong Malaria Elimination Programme: Epidemiology Summary, Vol. 20. (World Health Organization, Geneva, 2023)."},{"key":"59946_CR31","unstructured":"Global Malaria Programme (GMP). Report on Antimalarial Drug Efficacy, Resistance and Response: 10 Years of Surveillance (2010-2019) (World Health Organization, Geneva, 2020)."},{"key":"59946_CR32","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/S1473-3099(22)00697-1","volume":"23","author":"V Wasakul","year":"2023","unstructured":"Wasakul, V. et al. Malaria outbreak in Laos driven by a selective sweep for Plasmodium falciparum kelch13 R539T mutants: a genetic epidemiology analysis. Lancet Infect. Dis. 23, 568\u2013577 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"59946_CR33","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","volume":"364","author":"RN Price","year":"2004","unstructured":"Price, R. N. et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364, 438\u2013447 (2004).","journal-title":"Lancet"},{"key":"59946_CR34","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/ng.2624","volume":"45","author":"O Miotto","year":"2013","unstructured":"Miotto, O. et al. Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat. Genet. 45, 648\u2013655 (2013).","journal-title":"Nat. Genet."},{"key":"59946_CR35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ng.3189","volume":"47","author":"O Miotto","year":"2015","unstructured":"Miotto, O. et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat. Genet. 47, 226\u2013234 (2015).","journal-title":"Nat. Genet."},{"key":"59946_CR36","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/S1473-3099(20)30228-0","volume":"20","author":"M Imwong","year":"2020","unstructured":"Imwong, M. et al. Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study. Lancet Infect. Dis. 20, 1470\u20131480 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"59946_CR37","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S1473-3099(17)30048-8","volume":"17","author":"M Imwong","year":"2017","unstructured":"Imwong, M. et al. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study. Lancet Infect. Dis. 17, 491\u2013497 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"59946_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi2364","volume":"9","author":"S Mok","year":"2023","unstructured":"Mok, S. et al. Mapping the genomic landscape of multidrug resistance in Plasmodium falciparum and its impact on parasite fitness. Sci. Adv. 9, eadi2364 (2023).","journal-title":"Sci. Adv."},{"key":"59946_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-022-04279-3","volume":"21","author":"D Lek","year":"2022","unstructured":"Lek, D. et al. Efficacy of three anti-malarial regimens for uncomplicated Plasmodium falciparum malaria in Cambodia, 2009\u20132011: a randomized controlled trial and brief review. Malar. J. 21, 259 (2022).","journal-title":"Malar. J."},{"key":"59946_CR40","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1086\/503423","volume":"42","author":"RN Price","year":"2006","unstructured":"Price, R. N. et al. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clin. Infect. Dis. 42, 1570\u20131577 (2006).","journal-title":"Clin. Infect. Dis."},{"key":"59946_CR41","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1086\/507115","volume":"194","author":"AB Sidhu","year":"2006","unstructured":"Sidhu, A. B. et al. Decreasing pfmdr1 copy number in Plasmodium falciparummalaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J. Infect. Dis. 194, 528\u2013535 (2006).","journal-title":"J. Infect. Dis."},{"key":"59946_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11553","volume":"7","author":"MI Veiga","year":"2016","unstructured":"Veiga, M. I. et al. Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies. Nat. Commun. 7, 11553 (2016).","journal-title":"Nat. Commun."},{"key":"59946_CR43","doi-asserted-by":"crossref","unstructured":"Sisowath, C. et al. The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa. Trop. Med. Int. Health. 12, 736\u2013742 (2007).","DOI":"10.1111\/j.1365-3156.2007.01843.x"},{"key":"59946_CR44","doi-asserted-by":"publisher","unstructured":"Pryce, J., Taylor, M., Fox, T. & Hine, P. Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria. Cochrane Database Syst. Rev. CD006404 https:\/\/doi.org\/10.1002\/14651858.CD006404.pub4 (2022).","DOI":"10.1002\/14651858.CD006404.pub4"},{"key":"59946_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-8-11","volume":"8","author":"P Lim","year":"2009","unstructured":"Lim, P. et al. Pfmdr1copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malar. J. 8, 11 (2009).","journal-title":"Malar. J."},{"key":"59946_CR46","doi-asserted-by":"publisher","first-page":"e0191922","DOI":"10.1371\/journal.pone.0191922","volume":"13","author":"V Baraka","year":"2018","unstructured":"Baraka, V. et al. Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda. PLoS ONE 13, e0191922 (2018).","journal-title":"PLoS ONE"},{"key":"59946_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00141-5","author":"PJ Rosenthal","year":"2024","unstructured":"Rosenthal, P. J. et al. The emergence of artemisinin partial resistance in Africa: how do we respond? Lancet Infect. Dis. https:\/\/doi.org\/10.1016\/S1473-3099(24)00141-5 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"59946_CR48","doi-asserted-by":"publisher","unstructured":"Nsanzabana, C. et al. Molecular assays for antimalarial drug resistance surveillance: a target product profile. PLoS ONE 13, https:\/\/doi.org\/10.1371\/journal.pone.0204347 (2018).","DOI":"10.1371\/journal.pone.0204347"},{"key":"59946_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-020-03330-5","volume":"19","author":"R Noviyanti","year":"2020","unstructured":"Noviyanti, R. et al. Implementing parasite genotyping into national surveillance frameworks: feedback from control programmes and researchers in the Asia-Pacific region. Malar. J. 19, 1\u201320 (2020).","journal-title":"Malar. J."},{"key":"59946_CR50","unstructured":"Miotto, O. grcMalaria-R Package for Processing and Analyzing SpotMalaria Genetic Report Cards. V2.0.0. (GitHub, 2025)."},{"key":"59946_CR51","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2021)."},{"key":"59946_CR52","unstructured":"Areas, G. A. GADM database of Global Administrative Areas, version 2.0. www.gadm.org (2012)."},{"key":"59946_CR53","doi-asserted-by":"publisher","first-page":"22","DOI":"10.12688\/wellcomeopenres.18681.1","volume":"8","author":"MalariaGen","year":"2023","unstructured":"MalariaGen et al. Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples. Wellcome Open Res. 8, 22 (2023).","journal-title":"Wellcome Open Res."},{"key":"59946_CR54","doi-asserted-by":"crossref","unstructured":"Wickham, H. (2016). ggplot2: Elegant Graphics for Data Analysis (Springer-Verlag, 2016).","DOI":"10.1007\/978-3-319-24277-4"},{"key":"59946_CR55","unstructured":"Signorell, A. DescTools: Tools for Descriptive Statistics. R package version 0.99.54. https:\/\/andrisignorell.github.io\/DescTools\/ (2024)."},{"key":"59946_CR56","doi-asserted-by":"publisher","first-page":"P10008","DOI":"10.1088\/1742-5468\/2008\/10\/P10008","volume":"2008","author":"VD Blondel","year":"2008","unstructured":"Blondel, V. D., Guillaume, J.-L., Lambiotte, R. & Lefebvre, E. Fast unfolding of communities in large networks. J. Stat. Mech. Theory Exp. 2008, P10008 (2008).","journal-title":"J. Stat. Mech. Theory Exp."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59946-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59946-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59946-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T10:49:21Z","timestamp":1747738161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59946-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["59946"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-59946-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.06.06.24308535","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"18 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4689"}}